Trial intelligence / Profile preview

Sodium menatetrenone diphosphate tablets vs menatetrenone acetate tablets in acquired vitamin K–dependent coagulation factor deficiency

CTR20130573Phase 2Active

Sponsor
Wuxi Jialing Pharmaceutical
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of menatetrenone disodium diphosphate in hypoprothrombinemia, biliary colic, Biliary ascariasis, sponsored by Wuxi Jialing Pharmaceutical. Started Oct 2014; status: active.

02

Drugs

menatetrenone disodium diphosphate
03

Conditions

hypoprothrombinemiabiliary colicBiliary ascariasis

Beyond the preview

Go deeper on CTR20130573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call